English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jul 15, 2026

Researchers report new drug candidate reduces Parkinson's dyskinesia in animal studies

+ Pharmaceuticals
Patient Daily | Jul 15, 2026

Ohio State program supports maternal health for postpartum women and children

+ Pharmaceuticals
Patient Daily | Jul 15, 2026

Lilly explores maintenance dosing for Kisunla after amyloid clearance in Alzheimer’s patients

+ Pharmaceuticals
Patient Daily | Jul 15, 2026

American Lung Association launches campaign to raise awareness of expanded access programs

+ Pharmaceuticals
Patient Daily | Jul 15, 2026

Pfizer ends development of Seagen antibody-drug conjugate for solid tumors

+ Pharmaceuticals
Patient Daily | Jul 15, 2026

Local teens join statewide summit to address tobacco industry influence

+ Pharmaceuticals
Patient Daily | Jul 15, 2026

Biotech IPOs in first half of 2026 surpass last year’s total and set new records

+ Pharmaceuticals
Patient Daily | Jul 15, 2026

Career trajectories often shaped by small, overlooked decisions, article says

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

  • « First
  • «
  • …
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily